Cardiac angiosarcoma should be considered in the differential diagnosis of bloody pericardial effusions, even with negative early investigations, as it carries a poor prognosis.
Answers are grounded in this paper and cite their sources.
Supports early inclusion of cardiac angiosarcoma in bloody pericardial effusion differentials; leaves open the search for effective therapies given uniformly poor survival.
Primary cardiac angiosarcoma is extremely rare, but it is the most common primary malignant cardiac tumor. We herein present the case of a 51-year-old man who presented with symptoms of acute right heart failure, secondary to pericardial tamponade. Pericardiocentesis showed bloody fluid with negative pathology. Repeat 2-D echocardiography and a trans-esophageal echocardiogram showed a right atrial mass. The patient underwent surgery and adjuvant chemotherapy, but died seven months after the diagnosis. Despite being rare, cardiac angiosarcoma should be included in the differential diagnosis of bloody pericardial effusions, even with negative early investigations. The prognosis of the disease is usually poor. Treatment is mainly surgical resection if the cancer is localized, and can include neadjuvant and adjuvant chemotherapy, radiation treatment, and immunotherapy.
No takes yet. Share an insight, caveat, or question.
Chalhoub et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: